Daniella Kranjac is a Founding General Partner at Dynamk Capital. Daniella led Dynamk Capital’s investments in CellFE Biotech, Envisagenics, FloDesign Sonics (acquired by Millipore Sigma), RoosterBio, Virica Biotech, Xcell Biosciences, and others.
Prior to founding Dynamk Capital, she was CEO and Founder of Dynamk Consulting, providing capital, strategy, and business development consulting to leading life science companies and startups.
Before that, she was an entrepreneur and co-founded Wave Biotech LLC, driving the start-up, growth, and commercialization of highly disruptive technology. As Vice President of the organization, Daniella established a high-growth company with significant brand recognition and led the group to a successful exit and acquisition by GE Healthcare in 2007 (now Danaher/Cytiva).